Fig. 2From: A novel inflammatory biomarker, high-sensitivity C-reactive protein-to-albumin ratio, is associated with 5-year outcomes in patients with type 2 diabetes who undergo percutaneous coronary interventionKaplan–Meier estimates of the cumulative incidences for 5-year outcomes by strata of CAR. (A–B) Kaplan–Meier estimates of the cumulative incidences for all-cause mortality (A) and cardiac mortality (B). CAR: hs-CRP to albumin ratioBack to article page